60.57
price up icon0.40%   0.24
after-market After Hours: 60.57
loading
Catalent Inc stock is traded at $60.57, with a volume of 1.33M. It is up +0.40% in the last 24 hours and down -0.64% over the past month. Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply. Catalent has over 50 facilities across four continents.
See More
Previous Close:
$60.33
Open:
$60.3
24h Volume:
1.33M
Relative Volume:
0.78
Market Cap:
$10.92B
Revenue:
$4.38B
Net Income/Loss:
$-1.04B
P/E Ratio:
-46.59
EPS:
-1.3
Net Cash Flow:
$-59.00M
1W Performance:
+1.37%
1M Performance:
-0.64%
6M Performance:
+7.30%
1Y Performance:
+33.03%
1-Day Range:
Value
$60.05
$60.57
1-Week Range:
Value
$59.40
$60.57
52-Week Range:
Value
$31.80
$61.20

Catalent Inc Stock (CTLT) Company Profile

Name
Name
Catalent Inc
Name
Phone
(732) 537-6200
Name
Address
14 SCHOOLHOUSE ROAD, SOMERSET, NJ
Name
Employee
16,900
Name
Twitter
@catalentpharma
Name
Next Earnings Date
2024-08-27
Name
Latest SEC Filings
Name
CTLT's Discussions on Twitter

Catalent Inc Stock (CTLT) Upgrades & Downgrades

Date Action Analyst Rating Change
Nov-16-23 Upgrade Robert W. Baird Neutral → Outperform
Sep-05-23 Upgrade Argus Hold → Buy
Jul-20-23 Initiated Wells Fargo Equal Weight
Jul-05-23 Resumed JP Morgan Neutral
Jun-14-23 Downgrade Jefferies Buy → Hold
May-22-23 Downgrade JP Morgan Overweight → Neutral
May-15-23 Downgrade Deutsche Bank Buy → Hold
May-08-23 Downgrade BofA Securities Neutral → Underperform
Apr-17-23 Downgrade Robert W. Baird Outperform → Neutral
Apr-14-23 Downgrade William Blair Outperform → Mkt Perform
Apr-10-23 Upgrade Deutsche Bank Hold → Buy
Apr-03-23 Downgrade Barclays Overweight → Equal Weight
Dec-19-22 Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Nov-07-22 Downgrade Argus Buy → Hold
Nov-02-22 Downgrade BofA Securities Buy → Neutral
Dec-16-21 Initiated Barclays Overweight
Dec-10-20 Upgrade KeyBanc Capital Markets Sector Weight → Overweight
Jun-25-20 Initiated Argus Buy
Apr-21-20 Initiated RBC Capital Mkts Outperform
Mar-02-20 Initiated Deutsche Bank Hold
Oct-17-19 Resumed Stephens Overweight
Aug-28-19 Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Jun-21-19 Upgrade Jefferies Hold → Buy
Apr-16-19 Upgrade UBS Neutral → Buy
Nov-07-18 Upgrade First Analysis Sec Neutral → Outperform
Oct-09-18 Initiated UBS Neutral
Mar-28-18 Upgrade KeyBanc Capital Mkts Sector Weight → Overweight
Mar-21-18 Upgrade Raymond James Mkt Perform → Outperform
Feb-06-18 Downgrade Stephens Overweight → Equal-Weight
Sep-21-17 Upgrade Morgan Stanley Equal-Weight → Overweight
Sep-13-17 Initiated Needham Hold
Sep-08-17 Downgrade KeyBanc Capital Mkts Overweight → Sector Weight
Dec-01-16 Initiated Goldman Neutral
Oct-20-16 Initiated KeyBanc Capital Mkts Overweight
Jun-21-16 Upgrade Wells Fargo Market Perform → Outperform
Jun-20-16 Upgrade BofA/Merrill Neutral → Buy
View All

Catalent Inc Stock (CTLT) Latest News

pulisher
Sep 29, 2024

Summer 2025: InternEngineering - Built In

Sep 29, 2024
pulisher
Sep 29, 2024

BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Has $1.95 Million Holdings in Catalent, Inc. (NYSE:CTLT) - MarketBeat

Sep 29, 2024
pulisher
Sep 29, 2024

Pacer Advisors Inc. Acquires 6,011 Shares of Catalent, Inc. (NYSE:CTLT) - Defense World

Sep 29, 2024
pulisher
Sep 28, 2024

Millennium Management LLC Has $229.42 Million Stock Position in Catalent, Inc. (NYSE:CTLT) - Defense World

Sep 28, 2024
pulisher
Sep 28, 2024

ProShare Advisors LLC Has $1.71 Million Position in Catalent, Inc. (NYSE:CTLT) - Defense World

Sep 28, 2024
pulisher
Sep 28, 2024

Catalent, Inc. (NYSE:CTLT) Shares Bought by Squarepoint Ops LLC - MarketBeat

Sep 28, 2024
pulisher
Sep 27, 2024

Wall Street SWOT: Catalent stock faces merger scrutiny amid mixed financial results - Investing.com

Sep 27, 2024
pulisher
Sep 27, 2024

Catalent executive sells shares worth over $119,000 - Investing.com India

Sep 27, 2024
pulisher
Sep 27, 2024

Catalent executive sells shares worth over $119,000 - Investing.com

Sep 27, 2024
pulisher
Sep 27, 2024

Catalent executive sells shares worth over $119,000 By Investing.com - Investing.com Australia

Sep 27, 2024
pulisher
Sep 27, 2024

Pace Life Sciences Acquires Analytical Services Laboratory From Catalent - Contract Pharma

Sep 27, 2024
pulisher
Sep 27, 2024

David Mcerlane Sells 1,994 Shares of Catalent, Inc. (NYSE:CTLT) Stock - MarketBeat

Sep 27, 2024
pulisher
Sep 27, 2024

Catalent executive sells shares worth over $119,000 By Investing.com - Investing.com UK

Sep 27, 2024
pulisher
Sep 27, 2024

Leonard Green & Partners L.P. Sells 1,769,864 Shares of Catalent, Inc. (NYSE:CTLT) - MarketBeat

Sep 27, 2024
pulisher
Sep 27, 2024

Leonard Green & Partners L.P. Has $117.87 Million Stake in Catalent, Inc. (NYSE:CTLT) - MarketBeat

Sep 27, 2024
pulisher
Sep 26, 2024

Catalent Stock: Is CTLT Outperforming the Healthcare Sector? - Nasdaq

Sep 26, 2024
pulisher
Sep 26, 2024

Pace Life Sciences Expands Capacity and Capability With Acquisition of Catalent’s Analytical Services Laboratory in Research Triangle Park - AccessWire

Sep 26, 2024
pulisher
Sep 26, 2024

Pace Life Sciences Expands Capacity and Capability With Acquisition of Catalent’s Analytical Services Laboratory in Research Triangle Park - Yahoo Finance

Sep 26, 2024
pulisher
Sep 26, 2024

Catalent Stock: Is CTLT Outperforming the Healthcare Sector? - Barchart

Sep 26, 2024
pulisher
Sep 26, 2024

Clinical Trial Supplies Industry is Expected to Reach $8 Billion by 2030 -Almac Group Ltd, , Catalent Pharma Solutions, Inc., Parexel – Talented India - Talented India

Sep 26, 2024
pulisher
Sep 26, 2024

Catalent (NYSE:CTLT) Receives New Coverage from Analysts at StockNews.com - MarketBeat

Sep 26, 2024
pulisher
Sep 26, 2024

Catalent (NYSE:CTLT) Receives New Coverage from Analysts at StockNews.com - Defense World

Sep 26, 2024
pulisher
Sep 25, 2024

Traders Purchase High Volume of Catalent Put Options (NYSE:CTLT) - Defense World

Sep 25, 2024
pulisher
Sep 25, 2024

Caxton Associates LP Invests $16.60 Million in Catalent, Inc. (NYSE:CTLT) - Defense World

Sep 25, 2024
pulisher
Sep 25, 2024

Marshall Wace LLP Buys 86,533 Shares of Catalent, Inc. (NYSE:CTLT) - Defense World

Sep 25, 2024
pulisher
Sep 25, 2024

Catalent, Inc. (NYSE:CTLT) Shares Sold by Profund Advisors LLC - Defense World

Sep 25, 2024
pulisher
Sep 25, 2024

Catalent (NYSE:CTLT) Downgraded to “Hold” at Baird R W - Defense World

Sep 25, 2024
pulisher
Sep 25, 2024

Public Employees Retirement Association of Colorado Cuts Stock Position in Catalent, Inc. (NYSE:CTLT) - Defense World

Sep 25, 2024
pulisher
Sep 25, 2024

Catalent (NYSE:CTLT) Downgraded by Baird R W to Hold - MarketBeat

Sep 25, 2024
pulisher
Sep 25, 2024

Amalgamated Bank Decreases Stake in Catalent, Inc. (NYSE:CTLT) - Defense World

Sep 25, 2024
pulisher
Sep 25, 2024

Federated Hermes Inc. Has $159,000 Position in Catalent, Inc. (NYSE:CTLT) - Defense World

Sep 25, 2024
pulisher
Sep 25, 2024

Caxton Associates LP Invests $16.60 Million in Catalent, Inc. (NYSE:CTLT) - MarketBeat

Sep 25, 2024
pulisher
Sep 25, 2024

Catalent (NYSE:CTLT) Stock Rating Reaffirmed by Robert W. Baird - Defense World

Sep 25, 2024
pulisher
Sep 25, 2024

Clinical Trial Supplies Market 2031 Insights with Key Innovations Analysis |Almac Group Ltd, , Catalent Pharma Solutions, Inc., Parexe – Talented India - Talented India

Sep 25, 2024
pulisher
Sep 24, 2024

Catalent cut to neutral at Baird as analyst unable to find valuation in a deal break - Seeking Alpha

Sep 24, 2024
pulisher
Sep 24, 2024

AE Wealth Management LLC Boosts Holdings in Catalent, Inc. (NYSE:CTLT) - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

K2 Principal Fund L.P. Takes Position in Catalent, Inc. (NYSE:CTLT) - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Robert W. Baird Reiterates Neutral Rating for Catalent (NYSE:CTLT) - MarketBeat

Sep 24, 2024
pulisher
Sep 24, 2024

Slotnik Capital LLC Acquires 16,000 Shares of Catalent, Inc. (NYSE:CTLT) - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Catalent stock faces downgrade as buyout closes in, visibility remains lowBaird - Investing.com India

Sep 24, 2024
pulisher
Sep 24, 2024

K2 Principal Fund L.P. Invests $1.86 Million in Catalent, Inc. (NYSE:CTLT) - MarketBeat

Sep 24, 2024
pulisher
Sep 24, 2024

Catalent stock faces downgrade as buyout closes in, visibility remains lowBaird - Investing.com

Sep 24, 2024
pulisher
Sep 24, 2024

Catalent stock faces downgrade as buyout closes in, visibility remains lowBaird - Investing.com UK

Sep 24, 2024
pulisher
Sep 24, 2024

HighVista Strategies LLC Buys New Shares in Catalent, Inc. (NYSE:CTLT) - MarketBeat

Sep 24, 2024
pulisher
Sep 23, 2024

Notable Monday Option Activity: HUM, ADBE, VST - Nasdaq

Sep 23, 2024
pulisher
Sep 23, 2024

Catalent, Inc. (NYSE:CTLT) Shares Sold by Magnetar Financial LLC - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Fairscale Capital LLC Invests $36,000 in Caterpillar Inc. (NYSE:CAT) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Gabelli Funds LLC Lowers Holdings in Catalent, Inc. (NYSE:CTLT) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Hancock Whitney Corp Sells 131 Shares of Caterpillar Inc. (NYSE:CAT) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

HighVista Strategies LLC Takes Position in Catalent, Inc. (NYSE:CTLT) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Blair William & Co. IL Sells 2,292 Shares of Catalent, Inc. (NYSE:CTLT) - Defense World

Sep 23, 2024

Catalent Inc Stock (CTLT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$115.22
price up icon 0.14%
drug_manufacturers_specialty_generic RDY
$79.45
price down icon 0.28%
$11.61
price up icon 0.52%
$73.17
price down icon 0.18%
$109.75
price up icon 2.23%
Cap:     |  Volume (24h):